Principal Investigators

    PIERSON, RONALD

    Institution

    PIERSON BRAIN IMAGE ANALYSIS

    Contact information of lead PI

    Country

    USA

    Title of project or programme

    Unified high performance analysis of imaging biomarkers for Alzheimers disease

    Source of funding information

    NIH (NIA)

    Total sum awarded (Euro)

    € 1,651,376.15

    Start date of award

    15/08/2012

    Total duration of award in years

    5

    The project/programme is most relevant to:

    Alzheimer's disease & other dementias

    Keywords

    Acquired Cognitive Impairment... Aging... Alzheimer's Disease... Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)... Bioengineering... Brain Disorders... Dementia... Diagnostic Radiology... Neurodegenerative... Neurosciences

    Research Abstract

    DESCRIPTION (provided by applicant): Alzheimer’s disease is a neurodegenerative disease of the brain causing impairments to memory and cognitive functions, eventually leading to death. The causes of Alzheimer’s disease and mechanisms of disease progression are not fully understood, but an enormous amount of effort is being focused on the issues in research and pharmacologic interventions. Brain Image Analysis, LLC has developed NeuroAnalytica to provide high quality brain morphometry measures for biomarkers in Alzheimer’s disease. This Phase II project will expand the basic measures to include a wide range of modalities and measures that research has shown to be useful in as potential biomarkers in Alzheimer’s disease.

    Lay Summary

    PUBLIC HEALTH RELEVANCE: Alzheimer’s disease is a neurodegenerative disease of the brain causing impairments to memory and cognitive functions, eventually leading to death. The causes of Alzheimer’s disease and mechanisms of disease progression are not fully understood, but an enormous amount of effort is being focused on the issues in research and pharmacologic interventions. Brain Image Analysis, LLC has developed NeuroAnalytica to provide high quality brain morphometry measures for biomarkers in Alzheimer’s disease. This Phase II project will expand the basic measures to include a wide range of modalities and measures that research has shown to be useful in as potential biomarkers in Alzheimer’s disease.

    Further information available at:

Types: Investments > €500k
Member States: United States of America
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF